Fig 1.
Flow diagram for identifying and including studies in the current meta-analysis.
Table 1.
Meta-analysis of the association of GSTM1 polymorphism with risk of breast cancer.
Table 2.
Meta-analysis of the association of GSTT1 polymorphism with risk of breast cancer.
Table 3.
Meta-analysis of the association of GSTP1 polymorphism with risk of breast cancer.
Table 4.
Meta-analysis of the combined effects of GSTM1 present/null and GSTT1 present/null on breast cancer risk.
Table 5.
Meta-analysis of the combined effects of GSTM1 present/null and GSTP1 IIe105Val on breast cancer risk.
Table 6.
Meta-analysis of the combined effects of GSTT1 present/null and GSTP1 IIe105Val on breast cancer risk.
Table 7.
Meta-analysis of the combined effects of GSTM1 present/null, GSTT1 present/null and GSTP1 present/null on breast cancer risk.
Table 8.
Pooled estimates of association of GSTM1 polymorphism and breast cancer risk, only studies with high quality, matching, and genotyping examination done bindly or quality control.
Table 9.
Pooled estimates of association of the combined effects of GSTM1 present/null and GSTT1 present/null and breast cancer risk, only studies with high quality, matching, and genotyping examination done bindly or quality control.
Table 10.
Pooled estimates of association of GSTT1 polymorphism and breast cancer risk, only studies with high quality, matching, and genotyping examination done bindly or quality control.
Table 11.
Pooled estimates of association of GSTP1 polymorphism and breast cancer risk, only studies with controls in Hardy-Weinberg equilibrium, high quality, matching, and genotyping examination done bindly or quality control.
Table 12.
Pooled estimates of association of the combined effects of GSTM1 present/null and GSTP1 IIe105Val and breast cancer risk, only studies with high quality, matching, HWE, and genotyping examination done bindly or quality control.
Table 13.
False-positive report probability values for the current meta-analysis.
Table 14.
False-positive report probability values for the previous meta-analyses on GSTM1, GSTT1, and GSTP1 IIe105Val polymorphisms with breast cancer risk.